Related Experiment Video

Updated: Aug 12, 2026

One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
08:30

One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures

Published on: July 9, 2012

Antibiotic resistance in pediatric pathogens

A L Smith1

  • 1Department of Pediatrics, University of Washington, Seattle.

Infectious Disease Clinics of North America
|March 1, 1992
PubMed

Insights

Antibiotic resistance is rising in pediatric infections, particularly with Staphylococcus aureus, Staphylococcus epidermidis, and group A streptococci. Future pediatric antibiotic therapy will require novel antimicrobial agents due to increasing resistance.

Area of Science:

  • Pediatric Infectious Diseases
  • Antimicrobial Resistance
  • Microbiology

Background:

  • Increasing antibiotic resistance in pediatric pathogens poses a significant clinical challenge.
  • Specific concerns include methicillin resistance in Staphylococcus aureus and Staphylococcus epidermidis, and erythromycin resistance in group A streptococci.

Purpose of the Study:

  • To highlight the growing problem of antibiotic resistance in common pediatric bacterial pathogens.
  • To discuss the current susceptibility patterns and the implications for future treatment strategies.

Main Methods:

  • Literature review and analysis of current trends in pediatric antimicrobial resistance.
  • Examination of resistance mechanisms and susceptibility data for key pediatric pathogens.

Main Results:

  • Methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus epidermidis are increasing.
  • Erythromycin resistance in group A streptococci is a growing concern.
  • Haemophilus influenzae b is showing resistance to multiple antibiotics in some regions.

Conclusions:

  • Vancomycin remains effective against the discussed resistant staphylococci and streptococci.
  • The emergence of multidrug-resistant Haemophilus influenzae b necessitates careful monitoring.
  • Development of new antimicrobial agents is crucial for the future treatment of pediatric infections.

More Related Videos

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance09:00

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance

Published on: May 2, 2018

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes08:58

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes

Published on: March 3, 2023

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...